Clinical trial
Genetic Epidemiology of Responses to Antihypertensives
NCT00005520 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00005520 |
|---|---|
| Title | Genetic Epidemiology of Responses to Antihypertensives |
| Official title | Genetic Epidemiology of Responses to Antihypertensives |
| Acronym | GERA |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Heart Diseases, Hypertension |
| Intervention type | Drug |
| Interventions | Hydrochlorothiazide, Candesartan |
| Enrollment | 1,200 |
| Start date | Feb 1, 1997 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | May 26, 2000 |
| Last update posted | Jan 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: